| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesia and Intensive Care and
Department of Surgery, Pediatric Surgical Division, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
Address correspondence and reprint requests to Manoj K. Karmakar, FRCA, Associate Professor, The Chinese University of Hong Kong, Department of Anesthesia and Intensive Care, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Address e-mail to karmakar{at}cuhk.edu.hk
We compared the systemic absorption of ropivacaine and bupivacaine after caudal epidural administration in children. Twenty ASA physical status I or II children aged 17 yr undergoing elective hypospadias repair were randomized after the induction of general anesthesia to receive a single caudal epidural injection of 2 mg/kg of either ropivacaine 0.2% (R) or bupivacaine 0.2% (B) in a double-blinded fashion. Peripheral venous blood samples (1 mL) were obtained before and 1, 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, and 120 min after the caudal injection. The total R and B concentration was measured in plasma by using high-performance liquid chromatography. All blocks were successful, and there were no complications. The peak plasma concentration (mean ± SD) (R = 0.67 ± 0.16 and B = 0.73 ± 0.23 µg/mL) and the area under the plasma concentration curve (R = 61.9 ± 20.6 and B = 62.7 ± 18.2 µg · mL-1 · min-1) were comparable between the two study groups. The median (range) time to attain peak plasma concentration was significantly slower in children who received ropivacaine (R = 65 [10120] min and B = 20 [1550] min, P < 0.05). We conclude that ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than does bupivacaine.
IMPLICATIONS: We compared the systemic absorption of ropivacaine (0.2%) and bupivacaine (0.2%) after caudal epidural injection of 2 mg/kg in children aged 17 yr. Our results show that ropivacaine undergoes slower systemic absorption from the caudal epidural space in children than does bupivacaine.
This article has been cited by other articles:
![]() |
G. A. Chalkiadis, R. L. Eyres, N. Cranswick, R. H. Taylor, and S. Austin Pharmacokinetics of levobupivacaine 0.25% following caudal administration in children under 2 years of age{dagger} Br. J. Anaesth., February 1, 2004; 92(2): 218 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Van Obbergh, F. A. Roelants, F. Veyckemans, and R. K. Verbeeck In children, the addition of epinephrine modifies the pharmacokinetics of ropivacaine injected caudally: [Chez les enfants, l'addition d'epinephrine modifie la pharmacocinetique de la ropivacaine administree en injection caudale] Can J Anesth, June 1, 2003; 50(6): 593 - 598. [Abstract] [Full Text] [PDF] |
||||
|